These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9266322)

  • 1. Protein tyrosine phosphatases as stimulators and inhibitors of insulin signalling: possible candidates for insulin resistance.
    Kashiwagi A; Maegawa H; Kikkawa R
    Jpn J Physiol; 1997; 47 Suppl 1():S35-6. PubMed ID: 9266322
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathophysiology of insulin resistance.
    Sesti G
    Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):665-79. PubMed ID: 17161338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Roles of protein-tyrosine phosphatases in insulin-mediated signal transduction system].
    Noguchi T; Matozaki T; Kasuga M
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1200-8. PubMed ID: 9655980
    [No Abstract]   [Full Text] [Related]  

  • 4. Protein tyrosine phosphatase 1B as a target for the treatment of impaired glucose tolerance and type II diabetes.
    Liu G; Trevillyan JM
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1608-16. PubMed ID: 12476961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein tyrosine phosphatase 1B inhibitors for the treatment of type 2 diabetes and obesity: recent advances.
    Harley EA; Levens N
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1179-89. PubMed ID: 14649209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C.
    Bernsmeier C; Duong FH; Christen V; Pugnale P; Negro F; Terracciano L; Heim MH
    J Hepatol; 2008 Sep; 49(3):429-40. PubMed ID: 18486982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice.
    Mueller AS; Pallauf J
    J Nutr Biochem; 2006 Aug; 17(8):548-60. PubMed ID: 16443359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiology of impaired insulin sensitivity in the perioperative period].
    Assmann A; Spranger J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2011 Apr; 46(4):250-5; quiz 256. PubMed ID: 21484620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling.
    Cho CY; Koo SH; Wang Y; Callaway S; Hedrick S; Mak PA; Orth AP; Peters EC; Saez E; Montminy M; Schultz PG; Chanda SK
    Cell Metab; 2006 May; 3(5):367-78. PubMed ID: 16679294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5.
    Mziaut H; Trajkovski M; Kersting S; Ehninger A; Altkrüger A; Lemaitre RP; Schmidt D; Saeger HD; Lee MS; Drechsel DN; Müller S; Solimena M
    Nat Cell Biol; 2006 May; 8(5):435-45. PubMed ID: 16622421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knock-down of LAR protein tyrosine phosphatase induces insulin resistance.
    Mander A; Hodgkinson CP; Sale GJ
    FEBS Lett; 2005 Jun; 579(14):3024-8. PubMed ID: 15896785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II-induced insulin resistance and protein tyrosine phosphatases.
    Marrero MB; Fulton D; Stepp D; Stern DM
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2009-13. PubMed ID: 15271787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The brown adipose cell: a model for understanding the molecular mechanisms of insulin resistance.
    Valverde AM; Benito M; Lorenzo M
    Acta Physiol Scand; 2005 Jan; 183(1):59-73. PubMed ID: 15654920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants.
    Haase H; Maret W
    Biometals; 2005 Aug; 18(4):333-8. PubMed ID: 16158225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of regulation of the extracellular signal-regulated kinases in the pancreatic beta-cell line MIN6 and their implication in the regulation of insulin gene transcription.
    Benes C; Poitout V; Marie JC; Martin-Perez J; Roisin MP; Fagard R
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):219-25. PubMed ID: 10229678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOCS proteins causing trouble in insulin action.
    Lebrun P; Van Obberghen E
    Acta Physiol (Oxf); 2008 Jan; 192(1):29-36. PubMed ID: 18171427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein tyrosine phosphatase regulation in fibroblasts from patients with an insulin receptor gene mutation.
    Seki N; Yagi S; Suzuki Y; Shimada F; Taira M; Makino H; Amano K; Yagui K; Saito Y; Hashimoto N
    Horm Metab Res; 2008 Dec; 40(12):833-7. PubMed ID: 18925540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin signaling and insulin resistance].
    Ferré P
    Therapie; 2007; 62(4):277-84. PubMed ID: 17983553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKCtheta is a key player in the development of insulin resistance.
    Haasch D; Berg C; Clampit JE; Pederson T; Frost L; Kroeger P; Rondinone CM
    Biochem Biophys Res Commun; 2006 May; 343(2):361-8. PubMed ID: 16545776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.